Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRM-001 vs YVOIRE Hydro for correction of crow's feet wrinkles
KCT0000959Phase 3Completed
- Sponsor
- Gangwon Institute for Regional Program Evaluation
- Start
- Apr 2013
- Modality
- DNA Therapeutics → Nucleic Acid Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of PRM-001 (2 arms), sponsored by Gangwon Institute for Regional Program Evaluation. Started Apr 2013; status: completed.
02
Drugs
PRM-001
Beyond the preview
Go deeper on KCT0000959.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000959.